Changing trends in elective splenectomy at a tertiary hospital in North India - a 10year study
DOI:
https://doi.org/10.18203/2349-2902.isj20173394Keywords:
Elective splenectomy, Hypersplenism, Primary Hypersplenism, secondary Hypersplenism, SplenectomyAbstract
Background: Spleen is the meeting ground of medicine and surgery and most patients for elective splenectomy are primarily evaluated by physicians and then referred to the surgeons. Both physicians and surgeons need to be aware of the utility of splenectomy as a therapeutic option in various medical conditions. This study looks at the indications for elective splenectomy and the outcomes over a decade at a tertiary care centre in North India. It also evaluates the adherence to protocols recommended for prevention of OPSI in adults.
Methods: A hospital based prospective observational study was conducted at a tertiary care hospital situated in Uttarakhand, North India, over a duration of 10 years from October 2006 to October 2016. The inclusion criteria for the study were all the patients undergoing splenectomy for the non-traumatic indications.
Results: Sixty-one patients underwent splenectomy in the 10 years’ duration. The age range of patients was from 17-79 years with twenty-six males and rest females. Hypersplenism was the commonest indication for splenectomy. There were eleven cases of primary hypersplenism and there were twenty-five cases of secondary hypersplenism. Portal hypertension was the main cause of secondary hypersplenism requiring splenectomy.
Conclusions: The major indications of elective splenectomy were hypersplenism secondary to portal hypertension due to EHPVO and haematological disorders mainly ITP. Mortality is 2.4% and morbidity is 21.4%. Vaccination rates of 75% were seen in planned splenectomy however, no case of OPSI recorded in this series.
Metrics
References
JM Glass, JM Gilbert. Splenectomy in a general hospital. J R Soc Med. 1996; 89:199-201.
Dionigi R, Boni L, Rausei S, Rovera F, Dionigi G. History of splenectomy. Int J Surg. 2013;11(S1):S42-43.
Morris DH, Bullock FD. The importance of the spleen in resistance to infection. Ann Surg. 1919;70:513-21.
King H, Schumacker HB. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg. 1952;136:239-42.
Holme TC, Crosby DL. Elective splenectomy. Indications and complications in 102 patients. J Coll Surg Edin. 1984;29:229-3.
Fellows IW, Hart S, Toghill PJ. Trends in splenectomy in the Trent region 1972-85. Postgrad Med J. 1988;64(750):267-70.
O'Neal BJ, McDonald JC. The risk of sepsis in the asplenic adult. Ann Surg. 1981;194:775-8.
Goonwardene A, Bourke JB, Ferguson R, Toghill, PJ. Splenectomy for undiagnosed splenomegaly. Br J Surg. 1979;66:62-5.
Wagner DS, Schlueter TM. Splenectomy: indications, complications and mortality. Ohio State Med J. 1984;80:610-13.
Worthy TS. Evaluation of diagnostic laparotomy and splenectomy in Hodgkin's disease. (Report No.12). Clin Radiol. 1981;32:523-36.
Traetow WD, Fabri PJ, Carey LC. Changing indications for splenectomy: thirty years experience. Arch Surg. 1980;115:447-51.
Holme TC, Crosby DL. Elective splenectomy. Indications and complications in 102 patients. J Coll Surg Edin. 1984;29:229-31.
Larson RA, Ultmann JE. The strategic role of laparotomy in staging Hodgkin's disease. Cancer Treat Rep. 1982;66:767-74.
Glass JM, Gilbert JM. Splenectomy in a general hospital. J R Soc Med. 1996;89:199-201
Dickerman JD. Traumatic asplenia in adults: a defined hazard? Arch Surg. 1981;116:361-3.
Musser G, Lazar G, Hocking W, Bussutil RW. Splenectomy for hematologic disease. The U.C.L.A. experience with 306 patients. Ann Surg. 1984;200:40.
Jockovich M, Mendenhall NP, Sompeck MD, Talbert JL, Copeland EM, Bland KI. Long term complications of laparotomy in Hodgkin’s disease. Ann Surg. 1994;219:615-24.
Hays DM, Ternberg JC, Chen TT. Complications related to 234 staging laparotomies performed in the intergroup hodgkin’s disease in childhood study. Surg. 1984:471-8.
Hosea SW, Brown EJ, Burch CG, Berg RA, Frank MM. Impaired immune response of splenectomized patients to polyvalent pneumo coccal vaccine. Lancet. 1981;i:804-7.
Kinnersley PK, Wilkinson CE, Srinivasan J. Pneumococcal vaccination after splenectomy: survey of hospital and primary care records. BMJ. 1993;307:1398-9.
Meshikhes AW, Mubarek MA, Abu-Alrahi AI, Al-Saif OH. The pattern of indications and complications of splenectomy in Eastern Saudi Arabia. Saudi Med J. 2004;25(12):1892-5.
Duckett JW. Splenectomy in treatment of secondary hypersplenism. Ann Surg. 1963;157:737-46.
Letoquart JP, La Gamma A, Kunin N, Grosbois B, Mambrini A, Leblay R. Splenectomy for splenomegaly exceeding 1,000 grams: analysis of 47 patients. Br J Surg. 1993;80:334-5.
Al-salem. Splenectomy for haematological diseases: The Qatif central hospital experience. Ann Saudi Med. 1999;19(4):325-30.
Kumar S, Diehn FE, Gertz MA, Tefferi A. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol. 2002;81(6):312-9.
Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, et al. Overview of 321 patients with idiopathic thrombocytopenic purpura. Ann Hematol. 2002;81(8):436-40.
Multani PS, Grossbard ML. Staging Laparotomy in the management of Hodgkin’s disease: is it still necessary?. Oncol. 1996;1:41-55.
Downloads
Published
How to Cite
Issue
Section
